Netter’s Atlas of Human Anatomy, 6e

Chủ biên: Frank H. Netter

Nhà xuất bản: Saunders

Năm xuất bản: 2014

Ngôn ngữ: English

The gold standard of excellence for 25 years, Frank H. Netter, MD’s Atlas of Human Anatomy offers unsurpassed depictions of the human body in clear, brilliant detail – all from a clinician’s perspective. With its emphasis on anatomic relationships and clinically relevant views, Dr. Netter’s work provides a coherent, lasting visual vocabulary for understanding anatomy and how it applies to medicine today.

Xem chi tiết

Hepatology A Clinical Textbook 5th edition

Chủ biên: Stefan Mauss, Thomas Berg, Jürgen Rockstroh, Christoph Sarrazin, Heiner Wedemeyer

Nhà xuất bản: Flying Publisher

Năm xuất bản: 2014

Ngôn ngữ: English

Hepatology is a rapidly evolving medical field and will continue to be very exciting over the next few decades. The situation in viral hepatitis is similar to the HIV field 10-15 years ago when it started to become better understood and treatable. Today, hepatitis B viral replication can be suppressed by potent antiviral drugs but there are risks for the emergence of resistance. Strategies to enhance the eradication rates of HBV infection still need to be developed. On the other hand, hepatitis C virus infection can be eradicated by treatment with pegylated interferon plus ribavirin. However, particularly in those infected by HCV genotype 1 the sustained virologic response rates are still suboptimal. Many new antiviral drugs, especially protease and polymerase inhibitors, are currently in preclinical and clinical development, and the first data from larger clinical trials provide some optimism that the cure rates for patients with chronic hepatitis C will be enhanced with these new agents. In other areas of hepatology, e.g., for hereditary and metabol ic liver diseases, our knowledge is rapidly increasing and new therapeutic options are on the horizon.
Are books in rapidly evolving areas such as hepatology the right medium to gather and summarize the current knowledge? Are these books not likely to be outdated the very day they are published? This is indeed a challenge that can be convincingly overcome only by rapid internet-based publishing with regular updates. Another unmatched advantage of a web-based book is the free and unrestricted access everywhere. Viral hepatitis and other liver diseases are a global burden and timely information is important for physicians, scientists, patients and health care officials all around the world.
The editors of this web-based book – Thomas Berg, Stefan Mauss, Jürgen Rockstroh, Christoph Sarrazin and Heiner Wedemeyer – are young, bright, and already internationally renowned hepatologists who have created an excellent state-of-the-art textbook on clinical hepatology. The book is well-structured and written and provides indepth information without being lengthy and redundant. I am convinced that all five will remain very active in the field and will update this book regularly as the science progresses. The book should rapidly become an international standard.

Frankfurt, 24 January 2009
​Stefan Zeuzem
 

Xem chi tiết

Hepatology a clinical textbook 2nd edition

Chủ biên: Stefan Mauss, Thomas Berg, Jürgen Rockstroh, Christoph Sarrazin, Heiner Wedemeyer

Nhà xuất bản: Flying Publisher

Năm xuất bản: 2010

Ngôn ngữ: English

Hepatology is a rapidly evolving medical field and will continue to be very exciting over the next few decades. The situation in viral hepatitis is similar to the HIV field 10-15 years ago when it started to become better understood and treatable. Today, hepatitis B viral replication can be suppressed by potent antiviral drugs but there are risks for the emergence of resistance. Strategies to enhance the eradication rates of HBV infection still need to be developed. On the other hand, hepatitis C virus infection can be eradicated by treatment with pegylated interferon plus ribavirin. However, particularly in those infected by HCV genotype 1 the sustained virologic response rates are still suboptimal. Many new antiviral drugs, especially protease and polymerase inhibitors, are currently in preclinical and clinical development, and the first data from larger clinical trials provide some optimism that the cure rates for patients with chronic hepatitis C will be enhanced with these new agents. In other areas of hepatology, e.g., for hereditary and metabol ic liver diseases, our knowledge is rapidly increasing and new therapeutic options are on the horizon.
Are books in rapidly evolving areas such as hepatology the right medium to gather and summarize the current knowledge? Are these books not likely to be outdated the very day they are published? This is indeed a challenge that can be convincingly overcome only by rapid internet-based publishing with regular updates. Another unmatched advantage of a web-based book is the free and unrestricted access everywhere. Viral hepatitis and other liver diseases are a global burden and timely information is important for physicians, scientists, patients and health care officials all around the world.
The editors of this web-based book – Thomas Berg, Stefan Mauss, Jürgen Rockstroh, Christoph Sarrazin and Heiner Wedemeyer – are young, bright, and already internationally renowned hepatologists who have created an excellent state-of-the-art textbook on clinical hepatology. The book is well-structured and written and provides indepth information without being lengthy and redundant. I am convinced that all five will remain very active in the field and will update this book regularly as the science progresses. The book should rapidly become an international standard.

Frankfurt, 24 January 2009
Stefan Zeuzem
 

Xem chi tiết

Hepatology a clinical textbook

Chủ biên: Stefan Mauss, Thomas Berg, Juergen Rockstroh, Christoph Sarrazin, Heiner Wedemeyer

Nhà xuất bản: Flying Publisher

Năm xuất bản: 2009

Ngôn ngữ: English

Hepatology is a rapidly evolving medical field and will continue to be very exciting over the next few decades. The situation in viral hepatitis is similar to the HIV field 10-15 years ago when it started to become better understood and treatable. Today, hepatitis B viral replication can be suppressed by potent antiviral drugs but there are risks for the emergence of resistance. Strategies to enhance the eradication rates of HBV infection still need to be developed. On the other hand, hepatitis C virus infection can be eradicated by treatment with pegylated interferon plus ribavirin. However, particularly in those infected by HCV genotype 1 the sustained virologic response rates are still suboptimal. Many new antiviral drugs, especially protease and polymerase inhibitors, are currently in preclinical and clinical development, and the first data from larger clinical trials provide some optimism that the cure rates for patients with chronic hepatitis C will be enhanced with these new agents. In other areas of hepatology, e.g., for hereditary and metabol ic liver diseases, our knowledge is rapidly increasing and new therapeutic options are on the horizon.
Are books in rapidly evolving areas such as hepatology the right medium to gather and summarize the current knowledge? Are these books not likely to be outdated the very day they are published? This is indeed a challenge that can be convincingly overcome only by rapid internet-based publishing with regular updates. Another unmatched advantage of a web-based book is the free and unrestricted access everywhere. Viral hepatitis and other liver diseases are a global burden and timely information is important for physicians, scientists, patients and health care officials all around the world.
The editors of this web-based book – Thomas Berg, Stefan Mauss, Jürgen Rockstroh, Christoph Sarrazin and Heiner Wedemeyer – are young, bright, and already internationally renowned hepatologists who have created an excellent state-of-the-art textbook on clinical hepatology. The book is well-structured and written and provides indepth information without being lengthy and redundant. I am convinced that all five will remain very active in the field and will update this book regularly as the science progresses. The book should rapidly become an international standard.
Frankfurt, 24 January 2009

Stefan Zeuzem
 

Xem chi tiết

International Textbook of Diabetes Mellitus 4e, 2-Volume Set

Chủ biên: R. A. DeFronzo

Nhà xuất bản: Wiley Blackwell

Năm xuất bản: 2015

Ngôn ngữ: English

The International Textbook of Diabetes Mellitus has been a successful, well-respected medical textbook for almost 20 years, over 3 editions. Encyclopaedic and international in scope, the textbook covers all aspects of diabetes ensuring a truly multidisciplinary and global approach. Sections covered include epidemiology, diagnosis, pathogenesis, management and complications of diabetes and public health issues worldwide. It incorporates a vast amount of new data regarding the scientific understanding and clinical management of this disease, with each new edition always reflecting the substantial advances in the field. Whereas other diabetes textbooks are primarily clinical with less focus on the basic science behind diabetes, ITDM’s primary philosophy has always been to comprehensively cover the basic science of metabolism, linking this closely to the pathophysiology and clinical aspects of the disease.

Xem chi tiết

Cardiology: An Illustrated Textbook, 2 Volume-Set, 1e

Chủ biên: Kanu Chatterjee

Nhà xuất bản: Jaypee Brothers Medical

Năm xuất bản: 2012

Ngôn ngữ: English

This two volume set presents recent advances in the knowledge and technology related to the field of cardiology. Beginning with a basic introduction, the text continues with a step by step approach through the subject, covering topics such as cardiovascular pharmacology, electrophysiology, coronary heart diseases, myocardial and pericardial disease and more. With contributions from leading international experts and over 1500 colour photographs, each chapter contains additional comments and guidelines from reputed international bodies. The book is accompanied by a DVD ROM containing high quality video footage of echocardiography.

Xem chi tiết

ANTI-TUBERCULOSIS DRUG RESISTANCE IN THE WORLD

Tác giả: World Health Organization

The primary aim of this report is to share survey and surveillance data on drug resistance in tuberculosis (TB). The data presented here are supplied largely by the programme managers who have led the work on surveys, but also by heads of reference laboratories and by principal investigators who may have been hired to assist the national TB programmes with the study. We thank all of them, and their staff, for their contributions. The World Health Organization/International Union Against Tuberculosis and Lung Disease (WHO/UNION) Global Project on Anti-Tuberculosis Drug Resistance Surveillance is carried out with the financial backing of United States Agency for International Development (USAID) and Eli Lilly and Company as part of the Lilly multidrug resistant (MDR)-TB Partnership. Drug resistance surveys were supported financially by the Dutch Government, the Global Fund, Japan International Cooperation Agency (JICA), Kreditanstalt für Wiederaufbau (KfW Entwicklungsbank), national TB programmes and USAID). The Supranational Reference Laboratory Network provided the external quality assurance, as well as technical support to many of the countries reporting. Technical support for surveys was provided by the Centers for Disease Control and Prevention (CDC), JICA, the Royal Netherlands Tuberculosis Association (KNCV), and WHO. Data for the WHO European Region were collected and validated jointly with EuroTB (Paris) — a European TB surveillance network funded by the European Commission.

Xem chi tiết